ASIA PACIFIC RAT MODEL MARKET FORECAST 2019-2027
The Asia-Pacific rat model generated $XX thousand in 2018. The market is expected to grow at a CAGR of 9.13% for the forecast period of 2019-2027 and is estimated to be worth $XX thousand by 2027. Increased availability of sample size and a close resemblance to human metabolic physiology are the major reasons for increased scientific interest in the rat-models and the subsequent market demand in the Asia-Pacific region.
ASIA PACIFIC RAT MODEL MARKET FORECAST 2019-2027
Asia Pacific Rat Model Market by Rat Type (Inbred, Genetically Engineered Rats, Surgically Modified Rats, Hybrid, Outbred, Immune-deficient) by Application (Diabetes, Toxicology, Oncology, Immunology & Inflammation, Other Application) by Component (Technology, Services, Rat Care Products) by Geography.
The Asia-Pacific rat model generated $XX thousand in 2018. The market is expected to grow at a CAGR of 9.13% for the forecast period of 2019-2027 and is estimated to be worth $XX thousand by 2027. Increased availability of sample size and a close resemblance to human metabolic physiology are the major reasons for increased scientific interest in the rat-models and the subsequent market demand in the Asia-Pacific region. The growing prevalence of chronic diseases has arisen the need for enhanced research studies to develop effective drugs which are attributing towards the adoption of a rat model within the regional market.
The countries analyzed for the Asia-Pacific market are India, China, Japan, South Korea, Australia and the Rest of Asia-Pacific. Supportive R&D incentive schemes for Contract Research Organizations (CROs) in Asian countries like China, Australia, and India combined with the expanding bio-pharmaceutical, and biotechnological sector is propelling the growth of the Asia Pacific rat model market. The emergence of advanced genome editing technologies, rapid and increased availability of transgenic rat models and increasing research and development in Asia-Pacific biotechnological companies are the major drivers for the boom in the rat model market.
The major player currently in the APAC rat model market are Clea Japan, Cyagen Biosciences Inc., Biomere, Charles River Laboratories Inc., Janvier Labs, Transviragen Inc., Hera Biolabs Inc., Vivo Biotech Ltd., Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Oncodesign S.A., Envigo, Laboratory Corporation of America Holdings, Taconic Biosciences, Genoway S.A. and Transposagen Biopharmaceuticals Inc.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- OUTBRED RAT TYPE HOLDS THE MAJOR SHARE IN THE RAT MODEL MARKET
- ONCOLOGY IS THE FASTEST GROWING APPLICATION
- RAT CARE PRODUCTS ARE SIGNIFICANTLY GROWING
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- ENHANCEMENT IN GENOME EDITING
- GROWING AVAILABILITY IN TRANSGENIC RAT
- SWELLING PHARMACEUTICAL AND BIOTECHNOLOGY CORPORATIONS R&D
- MARKET RESTRAINTS
- PRACTICE OF ANIMALS IN RESEARCH IS CONSIDERED UNETHICAL
- USE OF ZEBRAFISH IN RESEARCH IS THE GROWING MODEL
- IN VITRO AND ALTERNATIVE TESTING TECHNIQUES MODELS FOR RESEARCH
- MARKET OPPORTUNITIES
- PERSONALIZED MEDICINE ESTABLISHED TO SURGE DEMAND
- ESCALATION IN MONOCLONAL ANTIBODY CREATION
- MARKET CHALLENGES
- HIGHLY EXPENSIVE RAT MODEL
- MARKET BY RAT TYPE
- INBRED
- GENETICALLY ENGINEERED RATS
- SURGICALLY MODIFIED RATS
- HYBRID
- OUTBRED
- IMMUNE-DEFICIENT
- MARKET BY APPLICATION
- DIABETES
- TOXICOLOGY
- ONCOLOGY
- IMMUNOLOGY & INFLAMMATION
- OTHER APPLICATION
- MARKET BY COMPONENT
- TECHNOLOGY
- NUCLEAR TRANSFERASE
- MICROINJECTION
- EMBRYONIC STEM CELL INJECTION
- OTHER TECHNOLOGY
- SERVICES
- RAT CARE PRODUCTS
- FEED
- BEDDING
- CAGES
- OTHER RAT CARE PRODUCTS
- TECHNOLOGY
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE PRODUCT
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- INTENSITY OF COMPETITIVE RIVALRY
- VALUE CHAIN ANALYSIS
- REGULATORY FRAMEWORK
- KEY BUYING CRITERIA
- HIGH ACCURACY
- HIGH EFFICACY
- QUALITY OF OPERATING PROCEDURE
- PRICE
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- COMPETITIVE LANDSCAPE
- MARKET POSITION ANALYSIS
- COMPANY PROFILES
- BIOMERE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- CHARLES RIVER LABORATORIES INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CLEA JAPAN
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CYAGEN BIOSCIENCES INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- ENVIGO
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- GENOWAY S. A.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- HERA BIOLABS INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- JANVIER LABS
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- ONCODESIGN S.A.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- SAGE LABS INC. (ACQUIRED BY HORIZON DISCOVERY GROUP PLC.)
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TACONIC BIOSCIENCES
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TRANSPOSAGEN BIOPHARMACEUTICALS INC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TRANSVIRAGEN INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- VIVO BIOTECH LTD.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BIOMERE
TABLE LIST
TABLE 1 ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)
TABLE 2 BENEFITS OF TRANSGENIC RAT
TABLE 3 ASIA PACIFIC RAT MODEL MARKET BY RAT TYPE 2019-2027 ($ MILLION)
TABLE 4 EXAMPLES OF INBRED RATS AND RESEARCH APPLICATIONS
TABLE 5 ASIA PACIFIC INBRED MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC GENETICALLY ENGINEERED RATS MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC SURGICALLY MODIFIED RATS MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC HYBRID MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC OUTBRED MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC IMMUNE-DEFICIENT MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC RAT MODEL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC TOXICOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC ONCOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC IMMUNOLOGY & INFLAMMATION MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC RAT MODEL MARKET BY COMPONENT 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC NUCLEAR TRANSFERASE MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC MICRO INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC EMBRYONIC STEM CELL INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC OTHER TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC SERVICES MARKET 2019-2027 ($ MILLION)
TABLE 24 ASIA PACIFIC RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 25 ASIA PACIFIC FEED MARKET 2019-2027 ($ MILLION)
TABLE 26 POPULAR FOOD FOR RATS
TABLE 27 ASIA PACIFIC BEDDING MARKET 2019-2027 ($ MILLION)
TABLE 28 ASIA PACIFIC CAGES MARKET 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC OTHER RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 30 ASIA PACIFIC RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 31 RAT MODEL COMPANY POSITION ANALYSIS
FIGURES LIST
FIGURE 1 ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC RAT MODEL MARKET SHARE BY RAT TYPE 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC RAT MODEL MARKET BY INBRED 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC RAT MODEL MARKET BY HYBRID 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC RAT MODEL MARKET BY OUTBRED 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC RAT MODEL MARKET BY IMMUNE-DEFICIENT 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC RAT MODEL MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 10 PERCENTAGE OF DIABETES IN WORLD ADULT POPULATION IN 1980, 2015 AND 2040
FIGURE 11 ASIA PACIFIC RAT MODEL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC RAT MODEL MARKET BY TOXICOLOGY 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC RAT MODEL MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC RAT MODEL MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC RAT MODEL MARKET SHARE BY COMPONENT 2018 & 2027 (%)
FIGURE 17 ASIA PACIFIC RAT MODEL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC RAT MODEL MARKET BY NUCLEAR TRANSFERASE 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC RAT MODEL MARKET BY MICRO INJECTION 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2019-2027 ($ MILLION)
FIGURE 21 ASIA PACIFIC RAT MODEL MARKET BY OTHER TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC RAT MODEL MARKET BY SERVICES 2019-2027 ($ MILLION)
FIGURE 23 ASIA PACIFIC RAT MODEL MARKET BY RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 24 ASIA PACIFIC RAT MODEL MARKET BY FEED 2019-2027 ($ MILLION)
FIGURE 25 ASIA PACIFIC RAT MODEL MARKET BY BEDDING 2019-2027 ($ MILLION)
FIGURE 26 ASIA PACIFIC RAT MODEL MARKET BY CAGES 2019-2027 ($ MILLION)
FIGURE 27 ASIA PACIFIC RAT MODEL MARKET BY OTHER RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 28 PORTER’S FIVE FORCE MODEL
FIGURE 29 INDIA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 30 CHINA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 31 CHINESE PHARMACEUTICAL MARKET 2015 & 2020 ($ BILLION)
FIGURE 32 JAPAN RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 33 SOUTH KOREA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 34 AUSTRALIA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 35 REST OF ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF ASIA PACIFIC
- ASIA PACIFIC
- MARKET BY RAT TYPE
- INBRED
- GENETICALLY ENGINEERED RATS
- SURGICALLY MODIFIED RATS
- HYBRID
- OUTBRED
- IMMUNE-DEFICIENT
- MARKET BY APPLICATION
- DIABETES
- TOXICOLOGY
- ONCOLOGY
- IMMUNOLOGY & INFLAMMATION
- OTHER APPLICATION
- MARKET BY COMPONENT
- TECHNOLOGY
- NUCLEAR TRANSFERASE
- MICROINJECTION
- EMBRYONIC STEM CELL INJECTION
- OTHER TECHNOLOGY
- SERVICES
- RAT CARE PRODUCTS
- FEED
- BEDDING
- CAGES
- OTHER RAT CARE PRODUCTS
- TECHNOLOGY
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.